Heart Chip Outline
Microfluidic Cardiac Organ Chip is an in vitro technology that simulates the human cardiovascular system, utilizing microfluidic chip technology, biomaterials, cell culture and imaging to construct a miniature cardiovascular system with physiological structure and function.
The technology can simulate the physiological processes of the human cardiovascular system, such as heart contraction, vascular resistance and pressure changes.
Microfluidic cardiac organ chips usually consist of multiple microchannels and bioreactors, in which the microchannels can simulate blood vessels in the human cardiovascular system, and the bioreactors contain tissue cells such as cardiomyocytes, endothelial cells, and smooth muscle cells, which are used to simulate physiological processes such as myocardial contraction and vasodilation.
Micro-sensors and imaging systems can also be integrated on the chip for real-time monitoring and recording of physiological parameters and cellular response processes inside the chip.
The technology has a very broad application prospect and can be used in new drug screening, disease diagnosis, therapy and biological research.
Compared with traditional animal experiments, microfluidic cardiac organ chips can not only improve the accuracy and reproducibility of experiments, but also reduce the amount of animals used and the time of experiments, thus lowering the cost of research and the risk of ethical issues.
Experimental Methods for Brain Organ Chips
The experimental methods and approaches of microfluidic cardiac organ chips are usually divided into the following steps:
- Design and preparation of the chip: firstly, we need to design the structure and channel layout of the chip according to the experimental needs, and select suitable materials to prepare the chip. They are usually prepared using microfluidic chip fabrication techniques, including soft lithography, photolithography and electron beam etching.
- Cell culture and assembly of the chip: cells are cultured on the chip, including cardiomyocytes, endothelial cells and smooth muscle cells, etc. Assemble the cultured cells onto the chip according to the designed channel layout and establish the cell culture environment.
- Experimental operation: Use pumps, thermostats and other equipment to control the flow of fluid and changes in temperature to simulate physiological processes in the human cardiovascular system, such as heart contraction and changes in vascular resistance and pressure. Data can be recorded and analyzed by real-time monitoring of physiological parameters and cellular response processes inside the chip.
- Analysis of results: By analyzing and comparing the results of experiments, we can assess the effects of new drugs, study the mechanisms of diseases, and develop new therapies. Changes in cells and tissues inside the chip can be observed using imaging techniques such as fluorescence microscopy and confocal microscopy.
In conclusion, the microfluidic cardiac organ chip is a highly integrated bionic system, and the experimental methodology and approach require the synergistic cooperation of multiple technologies.
In addition to basic techniques such as cell culture and experimental manipulation, a high level of skill in microsensors, imaging techniques and data processing is required.
Recent Advances in Cardiac Organ Chips
A heart organ chip is a miniature device that mimics the structure and function of the human heart, usually made from a combination of microelectronics and cell culture technology.
These chips can be used to test new drugs and treatments for heart disease, thereby reducing the cost and time of drug development.
Here are the latest research advances in heart-organ microarrays:
- Preparation of Heart Tissue: Recent heart organ-on-a-chip research has shown that more accurate and reproducible heart models can be produced using autologous cells or combinations of multiple cell types. In addition, more realistic heart models can be produced through the use of 3D printing and other advanced manufacturing techniques.
- Microfluidics: Recent studies have shown that using microfluidics it is possible to precisely control cell culture environments, such as hydrodynamics and oxygen levels, among other factors, to better mimic the physiological conditions of the human heart.
- Dynamic Stimulation: Recent research has shown that the application of dynamic mechanical and electrical stimulation on cardiac organoids can better simulate the physiological state of the human heart. These stimuli can be controlled by microfluidics for more accurate simulations.
- APPLICATIONS: Recent research suggests that heart-organ chips can be used to test the effectiveness of new drugs and treatments. For example, researchers could use cardiac organ chips to test the effects of heart disease drugs, thereby improving the efficiency of new drug development.
Overall, the latest heart-organ-on-a-chip research suggests that more realistic and accurate models of the heart can be created using advanced technologies and methods, and that these models can be used to test the effectiveness of new drugs and treatments, thereby reducing the cost and time of drug development.
Recommended Literature Reading for Heart Organ Chips
Below are several papers on cardiac organ chips that cover research methods, techniques and applications of cardiac organ chips.
- "Human organs-on-chips: breaking the in vitro impasse" (Nature Reviews Drug Discovery, 2013). This article introduces the concept, history and current development of organ-on-chips and discusses their application in drug discovery. The article also introduces several methods and techniques for the preparation of cardiac organs-on-chips and discusses the potential of organs-on-chips in replacing animal experiments and accelerating drug discovery.
- "Organ-on-a-chip: a new platform for drug discovery" (Expert Opinion on Drug Discovery, 2016). This article explores the use of cardiac organoids in drug discovery and describes several methods and techniques for preparing cardiac organoids. The article also discusses the potential of organoids for studying drug toxicity and side effects, and how organoids compare to traditional in vitro and animal experiments.
- "Human heart on a chip: an in vitro model for cardiac cell therapy" (Biomaterials, 2016). This article describes a method for preparing a heart organ chip and uses the chip to simulate the therapeutic effects of cardiac cell transplantation. The article also explores the potential of heart organ chips for studying heart disease treatment, as well as their application for studying cardiomyocyte regeneration and functional recovery.
- "Heart-on-a-chip: an avenue to explore the effects of mechanical stimulation" (Biomedical Microdevices, 2019). This article describes a method for preparing heart organoids and explores the effects of mechanical stimulation on the chip on cardiomyocyte growth and differentiation. The article also discusses the potential of organoids to study cardiomyocyte development and mechanisms of heart disease onset.
Above are several literatures on cardiac organ chips, which cover the research methodology, technology and application of organ chips, and can provide references and insights for researchers and scholars.
Organ-on-a-chip model
Cell migration microarrays to study cell-to-cell interactions and the effects of perfusion versus diffusion-based, real-time analysis of experiments with all cell populations, Cell migration microarrays are designed to mimic the formation and transport of tight and gap junctions (e.g., the blood-brain barrier and other endothelial/tissue interfaces), and are available with a wide range of choices in channel sizes, tissue compartment sizes, and scaffolds, as well as barrier designs.
Slit Barrier or Pillar Barrier Options
Slit Barrier: This device utilizes slits spaced at regular intervals to form a barrier area between the outer and inner chambers.
Available standard design parameters include:
- Outer Channel Width (OC): 100 μm or 200 μm
- Stroke width (T): 50 μm or 100 μm
- Slit Spacing (SS): 50 µm or 100 µm
- Slit width (WS): 5um, variable
DXFLUIDICS
Dxfluidics is a specialized enterprise dedicated to customizing various microfluidic organ chips. With a highly skilled and experienced processing team, we offer one-stop organ chip processing services for our clients. The company is committed to providing high-quality, high-performance biochip products for the fields of biomedicine, biomedicine, bio-detection, cell culture, and more.
Let the flower of life bloom more beautifully, Dxfluidics microfluidic organ chips make miniature life experiments more precise!
ZH_CN 
EN